ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,277.51
0.80%
US Tech 100
18,064.80
0.02%
다우존스 지수
38,686.32
1.51%
Bitcoin
67,708.16
0.34%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. ProMIS Neurosciences Inc (PMN)

  7. ProMIS Neurosciences Inc (PMN) 뉴스

PMN

ProMIS Neurosciences (PMN)

ProMIS Neurosciences Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:PMN
일자시간출처헤드라인심볼기업
2024/05/1505:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMNProMIS Neurosciences Inc
2024/05/1505:01GlobeNewswire Inc.ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent HighlightsNASDAQ:PMNProMIS Neurosciences Inc
2024/04/3020:00GlobeNewswire Inc.ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed AntibodiesNASDAQ:PMNProMIS Neurosciences Inc
2024/04/0920:00GlobeNewswire Inc.ProMIS Neurosciences Publishes in the Journal of Biological Chemistry on the Interaction Between Pathogenic Proteins as a Treatment Target for ALSNASDAQ:PMNProMIS Neurosciences Inc
2024/04/0420:00GlobeNewswire Inc.ProMIS Neurosciences to Present in Upcoming Investor Conferences in April NASDAQ:PMNProMIS Neurosciences Inc
2024/04/0205:15GlobeNewswire Inc.ProMIS Neurosciences Announces Full Year 2023 Financial Results and Recent HighlightsNASDAQ:PMNProMIS Neurosciences Inc
2024/03/1120:00GlobeNewswire Inc.ProMIS Neurosciences Strengthens Global Intellectual Property PortfolioNASDAQ:PMNProMIS Neurosciences Inc
2024/02/2221:00GlobeNewswire Inc.ProMIS Neurosciences to Present at the 2024 BIO CEO & Investor ConferenceNASDAQ:PMNProMIS Neurosciences Inc
2024/01/2221:00GlobeNewswire Inc.ProMIS Neurosciences Achieves Milestone in Development of Therapeutic Alpha-Synuclein VaccineNASDAQ:PMNProMIS Neurosciences Inc
2024/01/0821:00GlobeNewswire Inc.ProMIS Neurosciences Issues Letter to ShareholdersNASDAQ:PMNProMIS Neurosciences Inc
2024/01/0321:00GlobeNewswire Inc.ProMIS Neurosciences, Inc. Announces Leadership TransitionNASDAQ:PMNProMIS Neurosciences Inc
2023/12/2021:00GlobeNewswire Inc.ProMIS Neurosciences Announces Publication on Novel Target for ALSNASDAQ:PMNProMIS Neurosciences Inc
2023/11/2021:00GlobeNewswire Inc.ProMIS Neurosciences Doses First Subjects in Phase 1a Clinical Trial of PMN310 to Treat Alzheimer’s DiseaseNASDAQ:PMNProMIS Neurosciences Inc
2023/11/1506:30GlobeNewswire Inc.ProMIS Neurosciences Announces Third Quarter 2023 Financial Results and Recent HighlightsNASDAQ:PMNProMIS Neurosciences Inc
2023/09/0820:00GlobeNewswire Inc.ProMIS Neurosciences Closes $20.4 Million Private Placement FinancingNASDAQ:PMNProMIS Neurosciences Inc
2023/09/0701:18GlobeNewswire Inc.ProMIS Neurosciences to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:PMNProMIS Neurosciences Inc
2023/08/2205:12GlobeNewswire Inc.ProMIS Neurosciences Announces $20.4 Million Private Placement FinancingNASDAQ:PMNProMIS Neurosciences Inc
2023/08/1506:33GlobeNewswire Inc.ProMIS Neurosciences Announces Second Quarter 2023 Financial Results and Recent HighlightsNASDAQ:PMNProMIS Neurosciences Inc
2023/07/1720:00GlobeNewswire Inc.ProMIS Showcases Preclinical Data at the Alzheimer’s Association International Conference 2023 on Computationally-Derived Antibody and Vaccine from Alzheimer’s PipelineNASDAQ:PMNProMIS Neurosciences Inc
2023/07/1420:45GlobeNewswire Inc.ProMIS Announces Completion of ContinuanceNASDAQ:PMNProMIS Neurosciences Inc
2023/07/1020:55GlobeNewswire Inc.ProMIS Neurosciences to Consolidate Trading on the Nasdaq ExchangeNASDAQ:PMNProMIS Neurosciences Inc
2023/06/3021:00GlobeNewswire Inc.ProMIS Neurosciences Holds Annual Meeting of Shareholders All Resolutions ApprovedNASDAQ:PMNProMIS Neurosciences Inc
2023/06/2921:00GlobeNewswire Inc.CORRECTION: Updated URL to Access ProMIS Annual Meeting of Shareholders on June 29, 2023 at 9:30am Eastern TimeNASDAQ:PMNProMIS Neurosciences Inc
2023/05/1606:00GlobeNewswire Inc.ProMIS Neurosciences Announces First Quarter 2023 Financial Results and Recent HighlightsNASDAQ:PMNProMIS Neurosciences Inc
2023/05/0822:00GlobeNewswire Inc.ProMIS Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for PMN310 in Alzheimer’s DiseaseNASDAQ:PMNProMIS Neurosciences Inc
2023/04/2606:00GlobeNewswire Inc.Data Presented at American Academy of Neurology Annual Meeting on Novel Vaccine Design for Alzheimer’s DiseaseNASDAQ:PMNProMIS Neurosciences Inc
2023/04/2420:30GlobeNewswire Inc.ProMIS Neurosciences Presents Preclinical Data Highlighting Targeting of Toxic Misfolded Proteins in Alzheimer’s Disease and ALS at American Academy of Neurology Annual MeetingNASDAQ:PMNProMIS Neurosciences Inc
2023/04/1020:30GlobeNewswire Inc.ProMIS Neurosciences Announces Submission of Investigational New Drug (IND) Application for Lead Antibody PMN310NASDAQ:PMNProMIS Neurosciences Inc
2023/03/2921:30GlobeNewswire Inc.Lead Therapeutic Candidate, PMN310, Demonstrates Enhanced Selectivity for Toxic Oligomers Compared to Other Amyloid-Beta-Directed Antibodies in Poster Presentation at AD/PD 2023NASDAQ:PMNProMIS Neurosciences Inc
2023/03/1322:00GlobeNewswire Inc.ProMIS Neurosciences Announces Abstracts Accepted for Presentation at the American Academy of Neurology 2023 Annual MeetingNASDAQ:PMNProMIS Neurosciences Inc
 검색 관련기사 보기:NASDAQ:PMN

최근 히스토리

NYSE
XOM
Exxon Mobil
AMEX
XLF
Financial Select Sector
NYSE
KO
Coca Cola
COIN
BTCUSD
Bitcoin
COIN
ETHUSD
Ethereum
NASDAQ
TSLA
Tesla
USOTC
ADDYY
Adidas (QX)
USOTC
BASFY
BASF (QX)
NYSE
VZ
Verizon Communications
USOTC
RHHBY
Roche (QX)
FX
USDEUR
US Dollar vs Euro
FX
USDGBP
US Dollar vs Sterling
CCOM
US500
US 500
NYSE
CVX
Chevron
NYSE
DIS
Walt Disney
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유